These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 317647)

  • 1. Assessment of immunobiological effects induced by chemicals, drugs or food additives. II. Studies with cyclophosphamide.
    Dean JH; Padarathsingh ML; Jerrells TR; Keys L; Northing JW
    Drug Chem Toxicol; 1979; 2(1-2):133-53. PubMed ID: 317647
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse.
    Kerckhaert JA; Van den Berg GJ; Willers JM
    Ann Immunol (Paris); 1974; 125(3):415-26. PubMed ID: 4606666
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of cyclophosphamide on the delayed hypersensitivity in the mouse after intraperitoneal immunization.
    Kerckhaert JA
    Ann Immunol (Paris); 1974 Jun; 125 C(4):559-68. PubMed ID: 4548829
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Bacillus Calmette-Guérin on immunosuppression from cyclophosphamide, methotrexate, and 5-fluorouracil.
    Sparks FC; Albert NE; Andreone PA; Breeding JH
    Cancer Res; 1977 Aug; 37(8 Pt 1):2560-4. PubMed ID: 326388
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis.
    Clements PJ; Yu DT; Levy J; Paulus HE; Barnett EV
    Arthritis Rheum; 1974; 17(4):347-53. PubMed ID: 4136699
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of methylpropionic acid and pyridazinone-3 derivatives on some immunologic and hemopoietic functions.
    Giełdanowski J; Paluska E; Hrubá A; Hraba T
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):335-44. PubMed ID: 6360076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of tumor allograft survival induced by CP-17,193.
    Otterness IG; Bliven ML
    Immunopharmacology; 1982 Aug; 4(4):341-54. PubMed ID: 6981629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice.
    Medina D; Stockman G; Griswold D
    Cancer Res; 1974 Oct; 34(10):2663-8. PubMed ID: 4607071
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.
    Turk JL; Parker D; Poulter LW
    Immunology; 1972 Oct; 23(4):493-501. PubMed ID: 4538884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of cyclosporin A: a new immunosuppressive agent.
    White DJ; Calne RY; Plumb A
    Transplant Proc; 1979 Mar; 11(1):855-9. PubMed ID: 377718
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cyclophosphamide and methylprednisolone on in vitro cellular immune response to allogeneic tumor cells. Correlation with in vivo rejection.
    Gerber M; Andress D; Pioch Y; Radal M; Serrou B
    Transplantation; 1978 Sep; 26(3):142-9. PubMed ID: 309196
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of interferon on cell-mediated immunity.
    De Maeyer E; De Maeyer-Guignard J
    Tex Rep Biol Med; 1977; 35():370-4. PubMed ID: 29358
    [No Abstract]   [Full Text] [Related]  

  • 15. The unique immunosuppressive activity of brequinar sodium.
    Jaffee BD; Jones EA; Loveless SE; Chen SF
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):19-22. PubMed ID: 7685954
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
    Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC
    Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective action of cyclophosphamide on T and B cell activity.
    Sigel MM; Huggins EM; Wood DM; Ghaffar A
    Prog Clin Biol Res; 1984; 161():241-8. PubMed ID: 6333031
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.
    Stockman GD; Heim LR; South MA; Trentin JJ
    J Immunol; 1973 Jan; 110(1):277-82. PubMed ID: 4539834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM; Botsmanov KV
    Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of thymus dependent and thymus independent antibody responses made by different numbers and populations of immunocompetent cells.
    Addison IE
    Br J Exp Pathol; 1974 Apr; 55(2):177-86. PubMed ID: 4151709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.